Suchergebnisse - "Jaeger, Ulrich"

PubPharm (212)

1

Daratumumab monotherapy in refractory warm autoimmune hemolytic anemia and cold agglutinin disease

enthalten in: Blood advances | 2024

von Jalink, M. | Jacobs, C. | Khwaja, J. | +15

2

Narcissistic dimensions and depressive symptoms in patients across mental disorders in cognitive behavioural therapy and in psychoanalytic interactional therapy in Germany : a prospective cohort study

enthalten in: The lancet. Psychiatry | 2023

von Richter, M. | Mota, S. | Hater, L. | +17

CommentIn: Lancet Psychiatry. 2023 Dec;10(12):914-916. - PMID 37844593

3

Mosunetuzumab in combination with CHOP in previously untreated DLBCL : safety and efficacy results from a phase 2 study

enthalten in: Blood advances | 2023

von Olszewski, A. | Phillips, T. | Hoffmann, M. | +15

4

Safety and efficacy of tisagenlecleucel plus pembrolizumab in patients with r/r DLBCL : phase 1b PORTIA study results

enthalten in: Blood advances | 2023

von Jaeger, U. | Worel, N. | McGuirk, J. | +7

5

Photovoltaics at multi-terawatt scale : Waiting is not an option

enthalten in: Science (New York, N.Y.) | 2023

von Haegel, N. | Verlinden, P. | Victoria, M. | +48

6

Pathological personality in relation to multiple domains of quality of life and impairment : Evidence for the specific relevance of the maladaptive poles of major trait domains

enthalten in: Journal of psychopathology and clinical science | 2023

von Hobbs, K. | Mann, F. | Latzman, R. | +4

7

Evaluation of Antibody Responses in Patients with B-Cell Malignancies after Two and Three Doses of Anti-SARS-CoV-2 S Vaccination-A Retrospective Cohort Study

enthalten in: Cancers | 2023

von Wirth, S. | Podar, K. | Pecherstorfer, M. | +3

8

Enduring undetectable MRD and updated outcomes in relapsed/refractory CLL after fixed-duration venetoclax-rituximab

enthalten in: Blood | 2022

von Seymour, J. | Kipps, T. | Eichhorst, B. | +18

CommentIn: Blood. 2022 Aug 25;140(8):797-798. - PMID 36006672

9

Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma

enthalten in: Blood advances | 2022

von Jaeger, U. | Tam, C. | Borchmann, P. | +27

10

Sustained sutimlimab response for 3 years in patients with cold agglutinin disease : A phase I, open-label, extension trial

enthalten in: British journal of haematology | 2022

von Gelbenegger, G. | Jaeger, U. | Fillitz, M. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[22]